Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. 2009

Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic. ales.imramovsky@faf.cuni.cz

A series of novel, highly antimicrobial salicylanilide esters of N-protected amino acids were synthesized and characterized. Their in vitro antimicrobial activity against eight fungal strains and Mycobacterium tuberculosis was determined. The compounds had the highest level of activity against Aspergillus fumigatus, Absidia corymbifera and Trichophyton mentagrophytes, and these levels were higher than that of the standard drug fluconazole. In addition, three compounds showed interesting antituberculosis activity, with inhibition ranging from 89% to 99%. (S)-4-Chloro-2-(4-trifluoromethylphenylcarbamoyl)-phenyl 2-benzyloxy-carbonylamino-propionate had the highest level of both antifungal and antimycobacterial activity. The structure-activity relationships of the new compounds are discussed.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001232 Aspergillus fumigatus A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals. Aspergillus fumigates,Neosartorya fumigata,Sartorya fumigata
D012458 Salicylanilides 2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes. N-Phenylsalicylamides,N Phenylsalicylamides
D014249 Trichophyton A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair. Endodermophyton,Trychophyton,Endodermophytons,Trichophytons,Trychophytons
D020095 Absidia A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans. Absidias

Related Publications

Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
November 1979, Journal of medicinal chemistry,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
November 1994, International journal of peptide and protein research,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
January 1967, Journal of the Chemical Society. Perkin transactions 1,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
December 1990, Biochemical Society transactions,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
January 2009, Bioorganic & medicinal chemistry letters,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
January 2008, Natural product research,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
June 2010, The Journal of organic chemistry,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
May 2014, The Journal of organic chemistry,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
December 1977, Journal of medicinal chemistry,
Ales Imramovský, and Jarmila Vinsová, and Juana Monreal Férriz, and Vladimír Buchta, and Josef Jampílek
January 2011, Current pharmaceutical design,
Copied contents to your clipboard!